An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
about
Structural and functional analysis of human prostatic acid phosphatase.Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's diseaseAdenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum.Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex.Metabotropic glutamate receptors: physiology, pharmacology, and disease.Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.Role of metabotropic glutamate receptors in the regulation of pancreatic functions.Development of [(123)I]IPEB and [(123)I]IMPEB as SPECT Radioligands for Metabotropic Glutamate Receptor Subtype 5.Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.Metabotropic glutamate receptor II in the brains of Parkinsonian patients.Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.Improved Syntheses of the Mglu₅ Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling.
P2860
Q30391641-EC7D4503-1AB3-4972-B5CB-666B316987EEQ34116613-AABA5C3B-A569-4B5E-BB29-C4459532BA13Q35065682-6209DE06-D8DC-4C01-8F9C-984680D7B7FFQ35193305-062CB879-4C3E-4B3A-B009-A4DC4A827A51Q35917127-D6355C91-732F-4698-B5D9-85AB1594B9D8Q36374309-8863C541-2B62-4267-98BA-D3B7E992807AQ37670222-0F8BD005-9407-40B3-81A6-6A2F963681C3Q38092819-8169A1B7-8DBE-4B41-B168-866149569CF7Q38172715-C658AAA6-A0B9-43DA-B118-A3CF82201F5AQ40808980-F01E32DA-6554-41BE-97AD-0E41FAC767F4Q41774971-15A5F848-708B-405C-8BEF-66D64339A996Q46087825-9E2EBFE5-F02B-43BE-B408-C6DFD15282CBQ48595216-1AEF194F-7EE7-49CF-B36A-2163F0733F89Q48598969-F132EE57-A4CD-4BDB-9C4B-F8410EF47FB8Q55236242-B12BBA3D-46BC-4B15-AEBF-131EADFFC9A2
P2860
An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
An influence of ligands of met ...... riatopallidal pathway in rats.
@ast
An influence of ligands of met ...... riatopallidal pathway in rats.
@en
type
label
An influence of ligands of met ...... riatopallidal pathway in rats.
@ast
An influence of ligands of met ...... riatopallidal pathway in rats.
@en
prefLabel
An influence of ligands of met ...... riatopallidal pathway in rats.
@ast
An influence of ligands of met ...... riatopallidal pathway in rats.
@en
P2093
P50
P1433
P1476
An influence of ligands of met ...... riatopallidal pathway in rats.
@en
P2093
Ossowska K
Pietraszek M
Wolfarth S
P2888
P304
P356
10.1007/S00726-006-0317-Y
P577
2006-05-15T00:00:00Z